CE-IVD and US-IVD
For accurate monitoring of BK polyomavirus (BKV) in transplant patients
The cobas® BKV test provides reliable, standardized, high-quality results for the improved management of transplant patients at risk of infection. Healthcare professionals use this test to assess if transplant patients are at risk of developing disease caused by BKV, which can contribute to graft loss or organ rejection. The test is for use on the automated cobas® 5800/6800/8800 Systems.
BKV could cause transplant-transmitted infections in immunocompromised transplant patients and is linked to post-transplant complications, such as nephropathy in kidney transplants and hemorrhagic cystitis in hematopoietic stem cell transplants.1,2 Early intervention with best-in-class monitoring tools provides actionable results which enable informed treatment decisions.
CE-IVD and US-IVD
Reference